Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Alemtuzumab in the treatment of multiple sclerosis.
From precursors to myelinating oligodendrocytes: Contribution of intrinsic and extrinsic factors to white matter plasticity in the adult brain.
Coenzyme Q10 supplementation and multiple sclerosis.
Modelling the natural history of primary progressive multiple sclerosis.
Latency of multifocal Visual Evoked Potentials in non-optic neuritis eyes of multiple sclerosis patients associated with optic radiation lesions.
Retrograde trans-synaptic degeneration in MS: A missing link?
Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis.
Dock3 protects myelin in the cuprizone model for demyelination.
A Potential Alternative against Neurodegenerative Diseases: Phytodrugs.
What's in the Literature?
Multiple sclerosis: getting personal with induced pluripotent stem cells.
Neural Crest Cells Isolated from the Bone Marrow of Transgenic Mice Express JCV T-Antigen.
Transient oscillatory dynamics of interferon beta signaling in macrophages.
Neurodegeneration: From Multiple Sclerosis to Alzheimer's Disease.
Cerebral venous thrombosis in a patient with clinically isolated spinal cord syndrome.
Inhibitory saccadic dysfunction is associated with cerebellar injury in multiple sclerosis.
Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration.
A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barré syndrome.
Goal oriented inpatient multiple sclerosis group.
Successful treatment of infliximab-associated immune-mediated sensory polyradiculopathy with intravenous immunoglobulin.
Cognitive and Clinical Dysfunction, Altered MEG Resting-State Networks and Thalamic Atrophy in Multiple Sclerosis.
[Multiple sclerosis: oral drugs].
Neuroimaging assessment of spasticity developed after acquired brain injuries and multiple sclerosis.
Cell-Based Reparative Therapies for Multiple Sclerosis.
Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.
Pages
« first
‹ previous
…
550
551
552
553
554
555
556
557
558
…
next ›
last »